UPDATE: Eiger BioPharmaceuticals (EIGR) Reports Expanded License Agreement with Merck (MRK) for Investigational Candidate Lonafarnib
Tweet Send to a Friend
(Updated - May 16, 2018 8:09 AM EDT)
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) announced today that it has expanded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) announced today that it has expanded ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
